echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Sinopharm "made in Wuhan" new crown vaccine approved for emergency use in people aged 3-17

    Sinopharm "made in Wuhan" new crown vaccine approved for emergency use in people aged 3-17

    • Last Update: 2021-08-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, after a demonstration organized by the relevant departments of the State Council’s joint prevention and control mechanism, the new coronavirus inactivated vaccine of the Wuhan Institute of Biological Products of Sinopharm Group was approved for emergency use in people aged 3-17


    From July 16, 2020, Wuhan Institute of Biological Products will carry out the "Phase III Clinical Trial of the New Coronary Inactivated Vaccine" in the UAE and other countries


    The 3-17-year-old age group of the new crown vaccine of the Sinopharm Wuhan Institute of Biological Products has completed phase I/II clinical trials under the auspices of the Henan Provincial Center for Disease Control and Prevention


    The 3-17-year-old age group of the new crown vaccine of the Sinopharm Wuhan Institute of Biological Products has completed phase I/II clinical trials under the auspices of the Henan Provincial Center for Disease Control and Prevention


    With the continuous emergence of mutant strains of the new crown, the construction of the immune barrier also urgently needs to be further expanded.


    On May 31, the second phase expansion project of the new crown inactivated vaccine of Sinopharm Wuhan Institute of Biological Products was officially completed and put into production.


    New crown pneumonia

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.